Brind.

Kura Oncology is seeking an Investigational New Drug (IND) application for its drug candidate KO-7246.

1 report, 1 independent Updated Sep 15

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

FDA Kura Oncology

Keep exploring

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
Kura Oncology
company in La Jolla, United States

Nothing else this week.

Related events

Kowa's New Drug Application (NDA) for drug K-911 was accepted by the FDA for review.Aug 27

Coverage

Newest first; wire copies grouped

Sep 15sdbj.com